SMN1 and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: CNVs such as exon deletion in SMN1 in SMA, exon deletion or duplication in dystrophinopathy, PMP22 duplication in Charcot–Marie–Tooth diseases could be evaluated by MLPA, specific GPS or WGS.